Journal Article

Cost analysis of the Spanish renal replacement therapy programme

Guillermo Villa, Ana Rodríguez-Carmona, Lucía Fernández-Ortiz, Jesús Cuervo, Pablo Rebollo, Alfonso Otero and Javier Arrieta

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 26, issue 11, pages 3709-3714
Published in print November 2011 | ISSN: 0931-0509
Published online March 2011 | e-ISSN: 1460-2385 | DOI:
Cost analysis of the Spanish renal replacement therapy programme

More Like This

Show all results sharing this subject:

  • Nephrology


Show Summary Details


Background. A cost analysis of the Spanish Renal Replacement Therapy (RRT) programme in the year 2010, for end-stage renal disease (ESRD) patients, was performed from the perspective of the Public Administration.

Methods. The costs associated with each RRT modality [hemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation (Tx)] were analysed. The Spanish ESRD incidence and prevalence figures in the year 2010 were forecasted in order to enable the calculation of an aggregate cost for each modality. Costs were mainly computed based on a review of the existing literature and of the Official Bulletins of the Spanish Autonomous Communities. Data from Oblikue Consulting eSalud health care costs database and from several Spanish public sources were also employed.

Results. In the year 2010, the forecasted incidence figures for HD, PD and Tx were 5409, 822 and 2317 patients, respectively. The forecasted prevalence figures were 22 582, 2420 and 24 761 patients, respectively. The average annual per-patient costs (incidence and prevalence) were €2651 and €37 968 (HD), €1808 and €25 826 (PD) and €38 313 and €6283 (Tx). Indirect costs amounted to €8929 (HD), €7429 (PD) and €5483 (Tx). The economic impact of the Spanish RRT programme on the Public Administration budget was estimated at ∼€1829 million (indirect costs included): €1327 (HD), €109 (PD) and €393 (Tx) million.

Conclusions. HD accounted for >70% of the aggregate costs of the Spanish RRT programme in 2010. From a costs minimization perspective, it would be preferable if the number of incident and prevalent patients in PD were increased.

Keywords: cost analysis; end-stage renal disease; haemodialysis; kidney transplantation; peritoneal dialysis

Journal Article.  3449 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.